Selected research
Industry Research
Juvenile Idiopathic Arthritis Diagnostic Industry Research Report 2026
Market perspective
The global Juvenile Idiopathic Arthritis Diagnostic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Juvenile Idiopathic Arthritis Diagnostic market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Juvenile Idiopathic Arthritis Diagnostic market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Juvenile Idiopathic Arthritis Diagnostic market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Juvenile Idiopathic Arthritis Diagnostic include Abbott, Roche, United Imaging, Philips, Thermo Fisher Scientific, Sysmex, Siemens Healthineers, Siemens and Hitachi, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Juvenile Idiopathic Arthritis Diagnostic market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Juvenile Idiopathic Arthritis Diagnostic.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Juvenile Idiopathic Arthritis Diagnostic Market by Company
Abbott
Roche
United Imaging
Philips
Thermo Fisher Scientific
Sysmex
Siemens Healthineers
Siemens
Hitachi
GE
Danaher
Canon Medical
BioMerieux
Juvenile Idiopathic Arthritis Diagnostic Segment by Type
Blood Tests
Imaging Scans
Juvenile Idiopathic Arthritis Diagnostic Segment by Application
Hospitals
Laboratories
Other
Juvenile Idiopathic Arthritis Diagnostic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Juvenile Idiopathic Arthritis Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Juvenile Idiopathic Arthritis Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Juvenile Idiopathic Arthritis Diagnostic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Juvenile Idiopathic Arthritis Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Tests
- Imaging Scans
Applications
- Hospitals
- Laboratories
- Other
Companies covered
- Abbott
- Roche
- United Imaging
- Philips
- Thermo Fisher Scientific
- Sysmex
- Siemens Healthineers
- Siemens
- Hitachi
- GE
- Danaher
- Canon Medical
- BioMerieux
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Juvenile Idiopathic Arthritis Diagnostic by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Tests
- 2.2.3 Imaging Scans
- 2.3 Juvenile Idiopathic Arthritis Diagnostic by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Laboratories
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Type
- 3.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Type (2021-2026)
- 3.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (2027-2032)
4 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Application
- 4.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Application (2021-2026)
- 4.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Perspective (2021-2032)
- 5.2 Global Juvenile Idiopathic Arthritis Diagnostic Growth Trends by Region
- 5.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Region (2021-2026)
- 5.2.3 Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (2027-2032)
- 5.3 Juvenile Idiopathic Arthritis Diagnostic Market Dynamics
- 5.3.1 Juvenile Idiopathic Arthritis Diagnostic Industry Trends
- 5.3.2 Juvenile Idiopathic Arthritis Diagnostic Market Drivers
- 5.3.3 Juvenile Idiopathic Arthritis Diagnostic Market Challenges
- 5.3.4 Juvenile Idiopathic Arthritis Diagnostic Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue
- 6.1.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue (2021-2026)
- 6.1.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021-2026)
- 6.2 Global Juvenile Idiopathic Arthritis Diagnostic Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic Head Office and Area Served
- 6.4 Global Juvenile Idiopathic Arthritis Diagnostic Players, Product Type & Application
- 6.5 Global Juvenile Idiopathic Arthritis Diagnostic Manufacturers Established Date
- 6.6 Global Juvenile Idiopathic Arthritis Diagnostic Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021-2032)
- 7.2 North America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021-2026)
- 7.4 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size (2021-2032)
- 8.2 Europe Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021-2026)
- 8.4 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size (2021-2032)
- 9.2 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021-2032)
- 10.2 South America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021-2026)
- 10.4 South America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size (2021-2032)
- 11.2 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.1.4 Abbott Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.2.4 Roche Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 United Imaging
- 12.3.1 United Imaging Company Information
- 12.3.2 United Imaging Business Overview
- 12.3.3 United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.3.4 United Imaging Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.3.5 United Imaging Recent Developments
- 12.4 Philips
- 12.4.1 Philips Company Information
- 12.4.2 Philips Business Overview
- 12.4.3 Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.4.4 Philips Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.4.5 Philips Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 Sysmex
- 12.6.1 Sysmex Company Information
- 12.6.2 Sysmex Business Overview
- 12.6.3 Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.6.4 Sysmex Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.6.5 Sysmex Recent Developments
- 12.7 Siemens Healthineers
- 12.7.1 Siemens Healthineers Company Information
- 12.7.2 Siemens Healthineers Business Overview
- 12.7.3 Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.7.4 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.7.5 Siemens Healthineers Recent Developments
- 12.8 Siemens
- 12.8.1 Siemens Company Information
- 12.8.2 Siemens Business Overview
- 12.8.3 Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.8.4 Siemens Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.8.5 Siemens Recent Developments
- 12.9 Hitachi
- 12.9.1 Hitachi Company Information
- 12.9.2 Hitachi Business Overview
- 12.9.3 Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.9.4 Hitachi Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.9.5 Hitachi Recent Developments
- 12.10 GE
- 12.10.1 GE Company Information
- 12.10.2 GE Business Overview
- 12.10.3 GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.10.4 GE Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.10.5 GE Recent Developments
- 12.11 Danaher
- 12.11.1 Danaher Company Information
- 12.11.2 Danaher Business Overview
- 12.11.3 Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.11.4 Danaher Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.11.5 Danaher Recent Developments
- 12.12 Canon Medical
- 12.12.1 Canon Medical Company Information
- 12.12.2 Canon Medical Business Overview
- 12.12.3 Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.12.4 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.12.5 Canon Medical Recent Developments
- 12.13 BioMerieux
- 12.13.1 BioMerieux Company Information
- 12.13.2 BioMerieux Business Overview
- 12.13.3 BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021-2026)
- 12.13.4 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
- 12.13.5 BioMerieux Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst